does glp 1 reduce insulin resistance The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 and Health: Beyond Weight

FDA approval of Vyleesi (the pharmaceutical formulation) provides an established clinical safety and pharmacology profile a significant advantage for researchers vs compounds with only preclinical data

For now, access to GLP1s for weight management remains limited to those with qualifying diagnoses, private insurance with strong benefits, or the financial means to pay out of pocket

If you're feeling extra tired, talk to your doctor about testing your B12 and iron levels

Effect of histone H4 tail on nucleosome stability and internucleosomal interactions

found that selenium deficiency in RAW 264.7 macrophages increases oxidative stress and enhances iNOS expression and NO production through heightened NF-B activation, suggesting seleniums key role in regulating inflammatory responses (Prabhu et al., 2002)

Roles of glucose-dependent insulinotropic polypeptide in diet-induced obesity